Vestibular evoked myogenic potentials in acute low-tone sensorineural hearing loss
- PMID: 15564839
- DOI: 10.1097/01.mlg.0000149452.83382.42
Vestibular evoked myogenic potentials in acute low-tone sensorineural hearing loss
Abstract
Objective/hypothesis: It was the authors' premise that the vestibular evoked myogenic potential (VEMP) test may be used to differentiate acute low-tone hearing loss (ALHL) from Meniere's disease with low-tone HL.
Study design: Prospective study.
Methods: From January 2000 to December 2002, consecutive 12 patients with ALHL and another 12 patients with definite Meniere's disease with low-tone HL were enrolled in this study. All patients underwent audiometry and VEMP test, before and after treatment with isosorbide for 3 consecutive months.
Results: Before treatment, 12 patients with ALHL revealed normal VEMPs (11, 92%) and augmented VEMPs (1). After treatment, 11 (92%) patients had resolved to normal hearing within 3 days. One year later, two (17%) patients progressed to Meniere's disease. In comparison with Meniere's disease, 6 (50%) of 12 patients showed normal VEMPs before treatment, and 7 (58%) patients had their hearing improved 3 months after treatment. Comparison of VEMP responses or hearing outcome between both groups exhibited significant differences.
Conclusion: Most patients with ALHL reveal normal VEMPs throughout the episode, indicating that the saccule is spared. In contrast, 50% of Meniere's disease patients with low-tone HL demonstrate abnormal VEMPs, showing a significant difference. Therefore, the VEMP test can be used to differentiate ALHL from Meniere's disease with low-tone HL.
Similar articles
-
Vestibular-evoked myogenic potential in the prediction of recovery from acute low-tone sensorineural hearing loss.Ear Hear. 2010 Apr;31(2):289-95. doi: 10.1097/AUD.0b013e3181c5b743. Ear Hear. 2010. PMID: 20054280 Clinical Trial.
-
Vestibular evoked myogenic potential (VEMP) in patients with Ménière's disease with drop attacks.Laryngoscope. 2006 May;116(5):776-9. doi: 10.1097/01.mlg.0000205129.78600.27. Laryngoscope. 2006. PMID: 16652086
-
Saccular dysfunction in Meniere's disease.Am J Otol. 1999 Mar;20(2):223-32. Am J Otol. 1999. PMID: 10100527
-
Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.Laryngoscope. 2007 Jan;117(1):3-15. doi: 10.1097/01.mlg.0000245058.11866.15. Laryngoscope. 2007. PMID: 17202923 Review.
-
Transtympanic electrocochleography in Menière's disease using clicks and tone-bursts.Am J Otol. 1993 May;14(3):290-4. Am J Otol. 1993. PMID: 8372928 Review.
Cited by
-
Cervical vestibular evoked myogenic potential (cVEMP) findings in adults with sensorineural hearing loss (SNHL): comparisons between 500 Hz tone burst and narrowband CE-Chirp stimuli.Sci Rep. 2023 Dec 21;13(1):22842. doi: 10.1038/s41598-023-48810-1. Sci Rep. 2023. PMID: 38129442 Free PMC article.
-
Functional and Molecular Markers for Hearing Loss and Vertigo Attacks in Meniere's Disease.Int J Mol Sci. 2023 Jan 28;24(3):2504. doi: 10.3390/ijms24032504. Int J Mol Sci. 2023. PMID: 36768827 Free PMC article. Review.
-
Clinical Characteristics and Short-term Outcomes of Acute Low Frequency Sensorineural Hearing Loss With Vertigo.Clin Exp Otorhinolaryngol. 2018 Jun;11(2):96-101. doi: 10.21053/ceo.2017.00948. Epub 2018 Jan 10. Clin Exp Otorhinolaryngol. 2018. PMID: 29310430 Free PMC article.
-
Predicting positive cochlear endolymphatic hydrops on magnetic resonance images.Laryngoscope Investig Otolaryngol. 2022 Jul 13;7(4):1178-1185. doi: 10.1002/lio2.869. eCollection 2022 Aug. Laryngoscope Investig Otolaryngol. 2022. PMID: 36000047 Free PMC article.
-
Preliminary study on cervical vestibular-evoked myogenic potentials tuning changes in acute low-tone sensorineural hearing loss.Eur Arch Otorhinolaryngol. 2025 Sep 3. doi: 10.1007/s00405-025-09661-w. Online ahead of print. Eur Arch Otorhinolaryngol. 2025. PMID: 40900325
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources